The latest study published in the New England Journal of Medicine, confirms that resistance to the current frontline antimalarial, artemisinin, is now present in Eastern Myanmar, Thailand and Southern Vietnam, as well as Western Cambodia.

Our understanding of the extent and nature of resistance in P. vivax parasites is largely unknown. WWARN’s new literature review summarises the global extent of reduced P. vivax susceptibility to the frontline antimalarial chloroquine. You can also download our new generic P. vivax protocol - we wel...